We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+10.11%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$47.1B
AUM Growth
+$2.61B
(+5.9%)
Cap. Flow
-$501M
Cap. Flow
% of AUM
-1.06%
Top 10 Holdings %
Top 10 Hldgs %
14.43%
Holding
3,576
New
705
Increased
706
Reduced
825
Closed
988
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$417M |
| 2 |
Meta Platforms (Facebook)
META
|
+$383M |
| 3 |
Amazon
AMZN
|
+$308M |
| 4 |
Microsoft
MSFT
|
+$293M |
| 5 |
GE Aerospace
GE
|
+$263M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$312M |
| 2 |
Bank of America
BAC
|
+$292M |
| 3 |
ExxonMobil
XOM
|
+$274M |
| 4 |
lululemon athletica
LULU
|
+$238M |
| 5 |
Qualcomm
QCOM
|
+$228M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.05% |
| 2 | Technology | 14.35% |
| 3 | Consumer Discretionary | 13.97% |
| 4 | Financials | 9.9% |
| 5 | Industrials | 6.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1951
Euroseas
ESEA
$536M
| $672K | ﹤0.01% |
44,772
-38,719
| -46% | -$599K |
|
1952
Generac Holdings
GNRC
$11.5B
| $671K | ﹤0.01% |
6,210
-400
| -6% | -$46.3K |
|
1953
Harte-Hanks
HHS
$16.4M
| $669K | ﹤0.01% |
71,111
+10,490
| +17% | +$116K |
|
|
TSVT
1954
DELISTED
2seventy bio
TSVT
| $669K | ﹤0.01% |
+65,558
| New | +$750K |
|
1955
OraSure Technologies
OSUR
$273M
| $669K | ﹤0.01% |
110,514
+56,930
| +106% | +$321K |
|
1956
Paymentus
PAY
$4.62B
| $668K | ﹤0.01% |
75,375
-9,364
| -11% | -$79K |
|
1957
iShares S&P India Nifty 50 Index Fund
INDY
$558M
| $666K | ﹤0.01% |
+16,200
| New | +$676K |
|
|
AVNS
1958
DELISTED
Avanos Medical
AVNS
| $663K | ﹤0.01% |
+22,300
| New | +$647K |
|
1959
Safe Bulkers
SB
$772M
| $663K | ﹤0.01% |
+179,700
| New | +$604K |
|
1960
Outdoor Holding Co
POWW
$249M
| $661K | ﹤0.01% |
335,570
| – | – |
|
|
VTLE
1961
DELISTED
Vital Energy
VTLE
| $658K | ﹤0.01% |
14,454
-68,567
| -83% | -$3.42M |
|
|
RWT
1962
Redwood Trust
RWT
$588M
| $655K | ﹤0.01% |
+97,110
| New | +$728K |
|
1963
RLX Technology
RLX
$2.37B
| $651K | ﹤0.01% |
224,514
+42,649
| +23% | +$103K |
|
|
PERF.WS
1964
CALL
DELISTED
Perfect Corp Warrants
PERF.WS
| $651K | ﹤0.01% |
108,840
-90,000
| -45% | -$14.7K |
|
1965
iShares US Insurance ETF
IAK
$521M
| $651K | ﹤0.01% |
+7,600
| New | +$690K |
|
1966
Orion
OEC
$403M
| $646K | ﹤0.01% |
+24,757
| New | +$560K |
|
|
VEEAW
1967
CALL
Veea Inc Warrant
VEEAW
| $643K | ﹤0.01% |
62,474
-117,522
| -65% | -$10.7K |
|
1968
Palomar
PLMR
$3.79B
| $643K | ﹤0.01% |
11,649
-83,111
| -88% | -$4.45M |
|
1969
Ezcorp Inc
EZPW
$1.79B
| $641K | ﹤0.01% |
74,573
-7,674
| -9% | -$67.5K |
|
1970
Delta Air Lines
DAL
$56.7B
| $640K | ﹤0.01% |
18,323
-282,463
| -94% | -$10.5M |
|
1971
CONMED
CNMD
$1.3B
| $639K | ﹤0.01% |
+6,156
| New | +$595K |
|
|
BMTX.WS
1972
CALL
DELISTED
BM Technologies, Inc. Warrants, each warrant exercisable for one share of Common Stock at an exercise price of $11.50
BMTX.WS
| $634K | ﹤0.01% |
180,000
-101,867
| -36% | -$39.3K |
|
1973
Amplify Cybersecurity ETF
HACK
$2.6B
| $633K | ﹤0.01% |
13,237
-4,433
| -25% | -$203K |
|
|
CONN
1974
DELISTED
Conn's Inc.
CONN
| $632K | ﹤0.01% |
104,356
+93,024
| +821% | +$792K |
|
|
NOA
1975
North American Construction
NOA
$357M
| $632K | ﹤0.01% |
37,867
+27,749
| +274% | +$431K |
|
Similar funds
Marshall Wace's Q1 2023 Portfolio in Review
As of Q1 2023, Marshall Wace held 3,576 positions worth $47.1B, up 5.9% from $44.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Marshall Wace's Q1 2023 filing shows 705 new, 706 increased, 825 reduced and 988 closed positions. Its largest new stake was Madrigal Pharmaceuticals: 541,764 shares worth $131M. The largest sale was Cigna, an estimated $312M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
- Marshall Wace's largest Q1 2023 buy was Madrigal Pharmaceuticals: 541,764 shares worth $131M.
- Marshall Wace added most to Walmart Inc in Q1 2023, an estimated $417M increase.
- Marshall Wace's biggest Q1 2023 reduction was Cigna, cutting an estimated $312M.
- Marshall Wace fully exited Merck in Q1 2023, selling an estimated $115M.
- Marshall Wace's ten largest holdings make up 14% of its $47.1B portfolio in Q1 2023.
- Marshall Wace opened 705 new positions and closed 988 in Q1 2023.
- Marshall Wace's portfolio value rose 5.9% quarter-over-quarter to $47.1B.
Based on Marshall Wace's 13F filing for Q1 2023, filed 15 May 2023.